We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology

News   Jun 20, 2017 | Original story from BMS

 
BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology
 
 
 

RELATED ARTICLES

Clinical Trial of Antiviral Drug To Treat Coronavirus Begins

News

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha.

READ MORE

Too Much of a Good Thing May Lead to Too Much of a Liver

News

A team of scientists suggest prolonged exposure to NRF2 and KEAP1 may contribute to enlargement of the liver and fatty liver diseases.

READ MORE

Ancient DNA From Sardinia Unlocks 6,000 Years of Genetic History

News

A new study of the genetic history of Sardinia, a Mediterranean island off the western coast of Italy, tells how genetic ancestry on the island was relatively stable through the end of the Bronze Age, even as mainland Europe saw new ancestries arrive

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE